1. Phospholipase iPLA2β Averts Ferroptosis By Eliminating A Redox Lipid Death Signal
- Author
-
Yoel Sadovsky, Ivet Bahar, Charleen T. Chu, Yu-Jia Zhai, Karolina Mikulska-Ruminska, Sergey Korolev, Timothy J Greenamyre, Jie Sun, Rong-Rong He, Alexandr A. Kapralov, Yulia Y. Tyurina, Haider H. Dar, Valerian E. Kagan, Hülya Bayır, Ming-Hai Pan, Teresa G. Hastings, Vladimir A. Tyurin, Hai-Biao Gong, Wanyang Sun, Ofer Beharier, Gaowei Mao, Ian J. Miller, Plamena R. Angelova, Andrew A. Amoscato, Andrey Y. Abramov, Dan-Hua Lu, Wen-Jun Duan, Indira H. Shrivastava, and Tamil S. Anthonymuthu
- Subjects
Scaffold protein ,Male ,Programmed cell death ,Leukotrienes ,Lipid Peroxides ,Iron ,Phosphatidylethanolamine Binding Protein ,Phospholipase ,medicine.disease_cause ,Article ,Pathogenesis ,Group VI Phospholipases A2 ,03 medical and health sciences ,chemistry.chemical_compound ,Mice ,medicine ,Animals ,Arachidonate 15-Lipoxygenase ,Ferroptosis ,Humans ,Molecular Biology ,Phospholipids ,030304 developmental biology ,Phosphatidylethanolamine ,0303 health sciences ,Mutation ,030302 biochemistry & molecular biology ,Neurodegeneration ,Parkinson Disease ,Cell Biology ,medicine.disease ,Lipid Metabolism ,Phenotype ,Lipids ,Cell biology ,Rats ,Mice, Inbred C57BL ,Disease Models, Animal ,chemistry ,Phospholipases ,Rats, Inbred Lew ,Female ,Oxidation-Reduction - Abstract
Ferroptosis, triggered by discoordination of iron, thiols and lipids, leads to the accumulation of 15-hydroperoxy (Hp)-arachidonoyl-phosphatidylethanolamine (15-HpETE-PE), generated by complexes of 15-lipoxygenase (15-LOX) and a scaffold protein, phosphatidylethanolamine (PE)-binding protein (PEBP)1. As the Ca2+-independent phospholipase A2β (iPLA2β, PLA2G6 or PNPLA9 gene) can preferentially hydrolyze peroxidized phospholipids, it may eliminate the ferroptotic 15-HpETE-PE death signal. Here, we demonstrate that by hydrolyzing 15-HpETE-PE, iPLA2β averts ferroptosis, whereas its genetic or pharmacological inactivation sensitizes cells to ferroptosis. Given that PLA2G6 mutations relate to neurodegeneration, we examined fibroblasts from a patient with a Parkinson's disease (PD)-associated mutation (fPDR747W) and found selectively decreased 15-HpETE-PE-hydrolyzing activity, 15-HpETE-PE accumulation and elevated sensitivity to ferroptosis. CRISPR-Cas9-engineered Pnpla9R748W/R748W mice exhibited progressive parkinsonian motor deficits and 15-HpETE-PE accumulation. Elevated 15-HpETE-PE levels were also detected in midbrains of rotenone-infused parkinsonian rats and α-synuclein-mutant SncaA53T mice, with decreased iPLA2β expression and a PD-relevant phenotype. Thus, iPLA2β is a new ferroptosis regulator, and its mutations may be implicated in PD pathogenesis.
- Published
- 2021